enVVeno Medical (NVNO) Non Operating Investment Income (2022 - 2026)
enVVeno Medical's (NVNO) quarterly Non Operating Investment Income came in at $238000.0 in Q1 2026, up 222.68% year-on-year from $73757.2 in Q1 2025, and up 118.83% quarter-over-quarter from -$1.3 million in Q4 2025.
enVVeno Medical (NVNO) Non Operating Investment Income (2022 - 2026) Analysis & Trends
enVVeno Medical's Non Operating Investment Income history runs 5 years deep, the most recent figure standing at $238000.0 for Q1 2026.
- On a quarterly basis, Non Operating Investment Income rose 222.68% year-over-year to $238000.0 in Q1 2026; TTM through Mar 2026 was -$1.1 million, a 285.71% decrease from a year earlier, with the FY2025 full-year figure at -$391000.0, down 123.84% from the prior year.
- Non Operating Investment Income advanced to $238000.0 in Q1 2026 per NVNO's latest filing, from -$1.3 million in the prior quarter.
- Across five years, Non Operating Investment Income topped out at $676000.0 in Q4 2023 and bottomed at -$1.3 million in Q4 2025.
- The 5-year median for Non Operating Investment Income is $115000.0 (2023), against an average of $62687.5.
- Across the five-year window, Non Operating Investment Income jumped 804.76% in 2023 and plunged 750.0% in 2025, its largest moves.
- Year by year, Non Operating Investment Income stood at $183000.0 in 2022, then jumped by 269.4% to $676000.0 in 2023, then slumped by 37.13% to $425000.0 in 2024, then tumbled by 397.41% to -$1.3 million in 2025, then surged by 118.83% to $238000.0 in 2026.
- Per Business Quant, the three latest NVNO Non Operating Investment Income figures stand at $238000.0 (Q1 2026), -$1.3 million (Q4 2025), and -$39000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | enVVeno Medical | 6.85 Mn | 6.85 Mn | - | 238,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 238,000.00 |
| Mar 31, 2026 | 238,000.00 |
| Dec 31, 2025 | -1.26 Mn |
| Dec 31, 2025 | -1.26 Mn |
| Sep 30, 2025 | -39,000.00 |
| Sep 30, 2025 | -39,000.00 |
| Jun 30, 2025 | -79,000.00 |
| Jun 30, 2025 | -79,000.00 |
| Mar 31, 2025 | -194,000.00 |
| Mar 31, 2025 | -194,000.00 |
| Dec 31, 2024 | 425,000.00 |
| Dec 31, 2024 | 425,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Sep 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 379,000.00 |
| Jun 30, 2024 | 379,000.00 |
| Mar 31, 2024 | 408,000.00 |
| Mar 31, 2024 | 408,000.00 |
| Dec 31, 2023 | 676,000.00 |
| Dec 31, 2023 | 676,000.00 |